Showing 641 - 660 results of 61,481 for search '(( 5 ((step decrease) OR (we decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 0.78s Refine Results
  1. 641

    Table_1_Manipulation of an α-glucosidase in the industrial glucoamylase-producing Aspergillus niger strain O1 to decrease non-fermentable sugars production and increase glucoamylas... by Wenzhu Guo (501328)

    Published 2022
    “…The total amounts of the transglycosylation products isomaltose and panose were significantly decreased in final strain B-P1-3 by 40.7% and 44.5%, respectively. …”
  2. 642
  3. 643
  4. 644
  5. 645
  6. 646
  7. 647
  8. 648
  9. 649

    Procedure related data, LBNP, LBPP and hypoxia. by Marcus Thudium (6441863)

    Published 2023
    “…Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”
  10. 650

    Individual biometric data of patients. by Marcus Thudium (6441863)

    Published 2023
    “…Decreasing levels of LBNP were applied in 5-minute steps until subjects reached presyncope. …”
  11. 651
  12. 652

    Datasheet1_Acquired von Willebrand syndrome (AVWS) type 2, characterized by decreased high molecular weight multimers, is common in children with severe pulmonary hypertension (PH)... by Ivonne Wieland (14112981)

    Published 2022
    “…Hemostatic complications were observed in 4 of 12 (33%) patients with VWS and 3 of 6 (50%) patients without diagnostics and therapy.</p>Conclusion<p>For children with moderate to severe PH, we recommend systematic analysis of von Willebrand variables, including multimer analysis, PFA-100 and platelet function testing. …”
  13. 653
  14. 654
  15. 655
  16. 656
  17. 657
  18. 658

    Ameliorative effect of nicotine exposure on insulin resistance is accompanied by decreased cardiac glycogen synthase kinase-3 and plasminogen activator inhibitor-1 during oral oest... by Olugbenga S. Michael (4410424)

    Published 2017
    “…</p> <p><b>Objective:</b> We hypothesized that nicotine would ameliorate insulin resistance (IR) that is accompanied by decreased cardiac glycogen synthase kinase-3 (GSK-3) and plasminogen activator inhibitor-1 (PAI-1).…”
  19. 659
  20. 660